Introduction
============

The use of biologic graft materials in complex abdominal wall reconstruction over the last several decades has significantly increased, especially in contaminated cases where synthetic mesh is relatively contraindicated. Two important potential complications after complex abdominal wall reconstruction are recurrence and infection. Several studies have shown that although recurrence rates are slightly lower in patients who have received synthetic mesh than in those who have received biologic graft material, the complication rates, especially the incidence of infection, are higher \[[@B1]\]. The morbidity associated with an infected synthetic mesh is greater than an infected biologic graft because management of an infected synthetic mesh requires antibiotics and removal of the foreign material, whereas infection of a biologic graft can be managed with antibiotics and wound care and does not typically require graft removal \[[@B2]\].

A recent study evaluating biologic graft biopsies obtained during re-exploration for ventral hernia recurrence revealed that the duration of time the biologic graft had been implanted was directly correlated with the degree of constructive remodeling. The human dermis scaffolds that had been implanted longer showed decreased numbers of inflammatory cells and fibrous encapsulation, increased extracellular matrix deposition and neovascularization, increased cellular penetration to the center of the biopsy, and nearly complete scaffold degradation \[[@B3]\].

Animal studies utilizing either porcine or human acellular dermal matrices showed that after several weeks, the tensile strength measurements of the abdominal wall at the biologic graft-to-musculofascia interface were not less, and in some cases were greater, than the adjacent unwounded fascia \[[@B4]-[@B6]\]. In addition, histological and immunohistochemical analysis demonstrated remodeling into fascia-like tissue with gene expression that was similar to the native fascia. For example, the surface of the biologic graft placed apposite to the bowel exhibited cellularity consistent with peritoneum and collagen fiber architecture similar to the alignment of native fascia \[[@B4]-[@B6]\]. This suggests an active regenerative process that allows for restoration of abdominal wall function. Despite the increasing popularity of biologic grafts in hernia repair, long-term histological evidence of biologic graft incorporation in humans is scarce as healed surgical sites are rarely revisited.

Case presentation
=================

A 69-year-old Caucasian man presented with recurrent metastatic carcinoid tumor to his liver. His past surgical history included gunshot wounds to his abdomen, resulting in an exploratory laparotomy in 1979. Four years later, a ventral hernia developed that was repaired primarily. His hernia recurred another 5 years later and was repaired with a polypropylene mesh.In 2009, he developed gastrointestinal symptoms of intermittent bloating, epigastric pain, abdominal cramps, and alternating episodes of diarrhea and constipation. With increased frequency and severity of symptoms, he subsequently developed a third recurrence of his ventral hernia in late 2010. A small bowel mass was visualized on a computed tomography scan in 2011 along with the recurrent ventral hernia (Figure [1](#F1){ref-type="fig"}A-D). This prompted serologic testing and radionuclide scanning studies that lead to a diagnosis of carcinoid tumor. An octreotide scan revealed uptake in his distal small bowel as well as the dome of his liver suspicious for metastatic carcinoid tumor with involvement of his liver.

![**Cross-sectional computed tomography images of patient pre-biologic graft placement. A**. Arrow indicates the carcinoid tumor. Presence of synthetic mesh is also shown. **B**-**D**. Additional caudad images demonstrating the presence of three synthetic meshes, mesh-associated seroma, and hernia recurrence due to separation of native fascia and mesh interface.](1752-1947-8-255-1){#F1}

He underwent exploratory laparotomy for the metastatic carcinoid tumor in March 2011. A 5cm right flank ventral hernia located at the edge of the polypropylene mesh was found. Extensive adhesiolysis, small bowel resection with primary anastomosis, cholecystectomy, intra-operative ultrasound-guided microwave ablation of segment 8 liver lesion (pathology positive for metastatic neuroendocrine carcinoma), and a ventral hernia repair were performed.

During the ventral hernia repair, the previously placed polypropylene mesh was removed. The hernia sac was excised and component separation consisting of a bilateral rectus abdominis muscle advancement flap was performed. His abdominal wall was reinforced with a 20cm×20cm non-cross-linked biologic hernia repair graft underlay (Biodesign^®^, Cook Medical, Bloomington, IN, USA) and secured with transfascial O Ethibond sutures (Ethicon, Blue Ash, OH, USA). The fascia edges were approximated primarily over the biologic graft with \#1 polydioxanone (PDS) and drains were placed in the subcutaneous layers. He recovered uneventfully.Thirty months after the carcinoid resection and liver tumor ablation, a repeat surveillance octreotide scan revealed a suspicious 1.9cm lesion on segment 1 of his liver that was confirmed with magnetic resonance imaging. Good fascial approximation at the site of the prior recurrent ventral hernia repair was also noted (Figure [2](#F2){ref-type="fig"}). He underwent surgery for recurrent metastatic carcinoid tumor ablation in October 2013. On visual inspection, there was no clear demarcation of the previously placed biologic graft except for the presence of the permanent transfascial Ethibond sutures (Figure [3](#F3){ref-type="fig"}). His native fascia was observed. Tissue biopsies of the incised midline fascia were obtained. Histology of the resected section revealed vascularized dense connective tissue (Figure [4](#F4){ref-type="fig"}).

![**Cross-sectional magnetic resonance images of patient 30 months after biologic graft placement. A**. Arrow indicates the recurrent carcinoid tumor in the liver. **B**-**D**. Additional caudad images demonstrating abdominal wall integrity.](1752-1947-8-255-2){#F2}

![**Intraoperative photo of fascia where underlay biologic graft was placed.** Intraoperative photo of fascia in the region of previously placed biologic graft with previously placed transfascial O Ethibond sutures (arrows). There was no visual evidence of graft material.](1752-1947-8-255-3){#F3}

![**Histology analysis of midline fascia edge sampling.** Vascularized dense connective tissue at previously placed biologic graft site. Blue ink indicates peritoneal edge of the fascia. **A**. 100× magnification. **B**. 200× magnification.](1752-1947-8-255-4){#F4}

Discussion
==========

Abdominal wall reconstruction with synthetic mesh or biologic graft reinforcement has reduced hernia recurrence as compared to primary repair. Mesh positioning can include onlay, underlay, interposition, or retrorectus placement. Underlay or retrorectus placement has been associated with lower recurrence rates \[[@B7]\].

Polyester, polypropylene, and polytetrafluoroethylene (PTFE) are several types of materials used in prosthetic mesh. The mechanism by which prosthetic mesh strengthens hernia repair is by inciting an intense inflammatory response to the foreign body with resultant development of a strong scar plate. The inflammatory changes around the alloplastic material used in abdominal wall defect repair can persist for many years \[[@B8]\]. This intense inflammatory response and subsequent scar plate formation can contribute to increased stiffness of the abdominal wall and shrinkage of the mesh. The use of "lightweight" mesh to decrease this inflammatory response has resulted in improved abdominal wall compliance and less mesh shrinkage \[[@B9]\]. In a clean abdomen without bacterial contamination, prosthetic mesh repair remains the standard of care for optimal long-term results.

The various types of biologic graft materials consist of a decellularized collagen matrix derived from either porcine, bovine or human sources. Typically obtained from either dermal or non-dermal sources these graft materials have undergone significant processing to remove the cells and antigenic components, resulting in a highly purified collagen architecture and surrounding extracellular matrix. Depending on the graft, the resulting product may or may not be cross-linked \[[@B10]\]. The theory behind the use of biologic grafts is that they provide scaffolding for cells and new blood vessels to infiltrate, support tissue regeneration, and can be used in the face of infection where synthetic materials are relatively contraindicated.

Common hernia mesh implant complications include recurrence, infection, seroma formation, integumentary necrosis, chronically draining sinuses, enterocutaneous fistulas, and intestinal obstruction \[[@B11]\]. Both classical synthetic mesh materials and the more modern acellular biologic graft materials may lead to post-hernia repair complications. In particular, a review of the literature has shown that postoperative complications involving synthetic meshes are more likely to lead to mesh extrusion and extended comorbid complications, such as a chronic inflammatory response resulting in chronic pain, sensation of feeling the mesh, and stiffness of the abdominal wall with loss of compliance \[[@B12]\]. These complications can necessitate removal of the mesh to fully resolve. However, complications involving many of the biologic graft implants, such as infection, are treated more conservatively \[[@B13]\].

Although a retrospective study assessing single-stage ventral hernia repairs with lightweight polypropylene mesh implants in clean-contaminated and contaminated cases has shown some favorable results, re-operation was 12% and the incidence of surgical site occurrences (surgical site infection, wound dehiscence, or wound breakdown) was 30% \[[@B14]\]. A systematic review of several retrospective studies utilizing biologic grafts showed an overall recurrence rate of 13.8%, which increased to 23.1% in contaminated/dirty repairs \[[@B15]\]. Biologic tissue matrices are commonly used in contaminated or infected surgical fields for one-stage repair with little to no subsequent graft removal, but hernia recurrence over a 5-year period may be greater than 50% \[[@B16]\]. Therefore, the durability of biologic grafts for single-stage repair in contaminated settings needs further evaluation \[[@B17]\]. Further prospective, randomized trials need to be conducted before practice guidelines are established.

Animal studies of various biologic graft materials on physicomechanical properties \[[@B18]\], immunological responses \[[@B19]\], neovascularization and collagen formation \[[@B20]\], and other correlates of tissue repair have been widely reported. The purported mechanism of hernia defect repair with biologic grafts is by integration of the biologic graft as a scaffold for tissue remodeling via neovascularization and tissue regeneration. However, histologic evidence of tissue remodeling after biologic graft placement is lacking in humans, as few patients undergo postoperative tissue analysis to verify the degree of graft incorporation. To demonstrate clinically the claim of tissue remodeling and graft incorporation as suggested by the animal data would require serial biopsies over time and would not be ethically feasible in any patient recovering uneventfully from complex hernia repair. The current case provides clinical evidence that long-term abdominal wall integrity was achieved in a patient with a third recurrence of ventral hernia following component separation repair using a biologic graft as a temporary scaffold.

Conclusions
===========

Several animal studies have shown that biologic grafts induce the expression of extracellular matrix components, remodeling enzymes, and inflammatory cytokines, and promote fibroblast infiltration and migration into the matrices. Our current observation suggests that tissue regeneration in humans may mirror that of the animal model. Improved tissue regeneration with implantation of biologic graft materials in animals may also be seen in humans.
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